Sfoglia per Autore
The V118I mutation as a marker of advanced HIV infection and disease progression
2007-01-01 Zaccarelli, M; Tozzi, V; Lorenzini, P; Forbici, F; Narciso, P; CECCHERINI SILBERSTEIN, F; Trotta, M; Bertoli, A; Liuzzi, G; Marconi, P; Mosti, S; Perno, Cf; Antinori, A
Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors
2007-10-01 CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study
2008-01-01 Santoro, M; Bertoli, A; Lorenzini, P; Lazzarin, A; Esposito, R; Carosi, G; Di Perri, G; Filice, G; Moroni, M; Rizzardini, G; Caramello, P; Maserati, R; Narciso, P; Cargnel, A; Antinori, A; Perno, Cf
Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART
2008-06-01 Tozzi, V; Bellagamba, R; Castiglione, F; Amendola, A; Ivanovic, J; Nicastri, E; Libertone, R; D'Offizi, G; Liuzzi, G; Gori, C; Forbici, F; D'Arrigo, R; Bertoli, A; Salvatori, M; Capobianchi, M; Antinori, A; Perno, Cf; Narciso, P
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients
2009-06-01 Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group
2010-07-01 Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia
2010-12-01 Svicher, V; Alteri, C; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Longo, R; Bernassola, M; Gallinaro, V; Romano, S; Visca, M; Ursitti, A; Feasi, M; Micheli, V; Angelico, M; Cassola, G; Parruti, G; Gubertini, G; De Sanctis, G; CECCHERINI SILBERSTEIN, F; Cappiello, G; Spanò, A; Perno, Cf
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf
Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development
2011-01-01 Svicher, V; Cento, V; Salpini, R; Mercurio, F; Fraune, M; Beggel, B; Han, Y; Gori, C; Wittkop, L; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, G; Fleury, H; Trimoulet, P; Angelico, M; Cappiello, G; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf
Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus
2011-01-01 Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.
2011-01-01 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
2011-01-01 Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf
Overlapping Structure of HBV genome and immune selecting pressure are the main driving forces for HBV evolution
2011-01-01 Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Guberino, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, M; Mazzotta, F; De Sanctis, G; Tremulet, P; Angelico, M; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V
The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion
2011-01-01 Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf
A case of Italian HIV-2 infection: a genetic analysis
2011-03-31 Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
2011-06-15 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
2011-11-09 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy
2011-11-23 Ceccarelli, L; Salpini, R; Sarmati, L; Svicher, V; Bertoli, A; Sordillo, P; Ricciardi, A; Perno, Cf; Andreoni, M; Sarrecchia, C
Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine
2011-12-09 Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V
Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo
2012-01-01 Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, V; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Perno, Cf
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2007 | The V118I mutation as a marker of advanced HIV infection and disease progression | Zaccarelli, M; Tozzi, V; Lorenzini, P; Forbici, F; Narciso, P; CECCHERINI SILBERSTEIN, F; Trotta, M; Bertoli, A; Liuzzi, G; Marconi, P; Mosti, S; Perno, Cf; Antinori, A | Articolo su rivista | |
| 1-ott-2007 | Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors | CECCHERINI SILBERSTEIN, F; Svicher, V; Sing, T; Artese, A; Santoro, M; Forbici, F; Bertoli, A; Alcaro, S; Palamara, G; d'Arminio Monforte, A; Balzarini, J; Antinori, A; Lengauer, T; Perno, Cf | Articolo su rivista | |
| 1-gen-2008 | Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study | Santoro, M; Bertoli, A; Lorenzini, P; Lazzarin, A; Esposito, R; Carosi, G; Di Perri, G; Filice, G; Moroni, M; Rizzardini, G; Caramello, P; Maserati, R; Narciso, P; Cargnel, A; Antinori, A; Perno, Cf | Articolo su rivista | |
| 1-giu-2008 | Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART | Tozzi, V; Bellagamba, R; Castiglione, F; Amendola, A; Ivanovic, J; Nicastri, E; Libertone, R; D'Offizi, G; Liuzzi, G; Gori, C; Forbici, F; D'Arrigo, R; Bertoli, A; Salvatori, M; Capobianchi, M; Antinori, A; Perno, Cf; Narciso, P | Articolo su rivista | |
| 1-giu-2009 | Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients | Santoro, M; Bertoli, A; Lorenzini, P; CECCHERINI SILBERSTEIN, F; Gianotti, N; Mussini, C; Torti, C; Di Perri, G; Barbarini, G; Bini, T; Melzi, S; Caramello, P; Maserati, R; Narciso, P; Micheli, V; Antinori, A; Perno, Cf | Articolo su rivista | |
| 1-lug-2010 | Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group | Svicher, V; D'Arrigo, R; Alteri, C; Andreoni, M; Angarano, G; Antinori, A; Antonelli, G; Bagnarelli, P; Baldanti, F; Bertoli, A; Borderi, M; Boeri, E; Bonn, I; Bruzzone, B; Callegaro, A; Cammarota, R; Canducci, F; CECCHERINI SILBERSTEIN, F; Clementi, M; Monforte, A; De Luca, A; Di Biagio, A; Di Gianbenedetto, S; Di Perri, G; Di Pietro, M; Fabeni, L; Fadda, G; Galli, M; Gennari, W; Ghisetti, V; Giacometti, A; Gori, A; Leoncini, F; Maggiolo, F; Maserati, R; Mazzotta, F; Micheli, V; Meini, G; Monno, L; Mussini, C; Nozza, S; Paolucci, S; Parisi, S; Pecorari, M; Pizzi, D; Quirino, T; Re, M; Rizzardini, G; Santangelo, R; Soria, A; Stazi, F; Sterrantino, G; Turriziani, O; Viscoli, C; Vullo, V; Lazzarin, A; Perno, Cf | Articolo su rivista | |
| 1-dic-2010 | Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia | Svicher, V; Alteri, C; Gori, C; Salpini, R; Marcuccilli, F; Bertoli, A; Longo, R; Bernassola, M; Gallinaro, V; Romano, S; Visca, M; Ursitti, A; Feasi, M; Micheli, V; Angelico, M; Cassola, G; Parruti, G; Gubertini, G; De Sanctis, G; CECCHERINI SILBERSTEIN, F; Cappiello, G; Spanò, A; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Role of hepatitis B virus genetic barrier in drug-resistance and immune-escape development | Svicher, V; Cento, V; Salpini, R; Mercurio, F; Fraune, M; Beggel, B; Han, Y; Gori, C; Wittkop, L; Bertoli, A; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, N; Mazzotta, F; De Sanctis, G; Fleury, H; Trimoulet, P; Angelico, M; Cappiello, G; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Signature mutations in V3 and bridging sheet domain of HIV-1 gp120 are specifically associated with dual tropism and modulate the interaction with CCR5 N-terminus | Alteri, C; Artese, A; Zang, J; Mercurio, F; Costa, G; Stazi, F; Fabeni, L; Bertoli, A; Forbici, F; Salpini, R; Dimonte, S; Alcaro, S; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V | Intervento a convegno | |
| 1-gen-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
| 1-gen-2011 | Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. | Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf | Articolo su rivista | |
| 1-gen-2011 | Overlapping Structure of HBV genome and immune selecting pressure are the main driving forces for HBV evolution | Cento, V; Mirabelli, C; Salpini, R; Han, Y; Mercurio, F; Dimonte, S; Beggel, B; Wittkop, L; Fraune, M; Gori, C; Bertoli, A; Micheli, V; Guberino, G; Longo, R; Romano, S; Visca, M; Gallinaro, V; Marino, M; Mazzotta, F; De Sanctis, G; Tremulet, P; Angelico, M; Zhang, X; Verheyen, J; CECCHERINI SILBERSTEIN, F; Perno, Cf; Svicher, V | Intervento a convegno | |
| 1-gen-2011 | The Lowest X4 Geno2Pheno-False Positive Rate Is Associated with Greater CD4-Depletion | Santoro, M; Armenia, D; Fabeni, L; Santoro, M; Gori, C; Forbici, F; Cento, V; Svicher, V; Bertoli, A; Dori, L; Andreoni, M; Narciso, P; Antinori, A; CECCHERINI SILBERSTEIN, F; Perno, Cf | Intervento a convegno | |
| 31-mar-2011 | A case of Italian HIV-2 infection: a genetic analysis | Ciccozzi, M; Babakir Mina, M; Cella, E; Bertoli, A; Lo Presti, A; Maniar, J; Perno, Cf; Ciotti, M | Articolo su rivista | |
| 15-giu-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
| 9-nov-2011 | Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf | Articolo su rivista | |
| 23-nov-2011 | Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy | Ceccarelli, L; Salpini, R; Sarmati, L; Svicher, V; Bertoli, A; Sordillo, P; Ricciardi, A; Perno, Cf; Andreoni, M; Sarrecchia, C | Articolo su rivista | |
| 9-dic-2011 | Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine | Alcaro, S; Alteri, C; Artese, A; CECCHERINI SILBERSTEIN, F; Costa, G; Ortuso, F; Bertoli, A; Forbici, F; Santoro, M; Parrotta, L; Flandre, P; Masquelier, B; Descamps, D; Calvez, V; Marcelin, A; Perno, Cf; Sing, T; Svicher, V | Articolo su rivista | |
| 1-gen-2012 | Key patterns of HBX and pre-S1/S2 mutations are involved in mechanisms underlying HBV-induced hepatocellular carcinoma in vivo | Svicher, V; Mirabelli, C; Cento, V; Salpini, R; Di Maio, V; Bertoli, A; Alteri, C; Pollicita, M; Gori, C; Micheli, V; Salso, A; Gubertini, G; Trimoulet, P; Fleury, H; Vecchiet, J; Iapadre, N; Barlattani, A; Mari, T; Pasquazzi, C; Sarrechia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Perno, Cf | Intervento a convegno |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile